在癌症中进行自重编程
Annie D Fuller1, Travis H Bordner1, Abigail J Staub1
1Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania, USA.
Journal of cellular physiology
|November 14, 2025
概括
自,细胞循环过程,支持癌细胞的生存和进展. 针对这种途径为各种癌症类型提供了一个有希望的治疗策略.
科学领域:
- 癌症生物学 癌症生物学
- 细胞代谢 细胞代谢
- 分子瘤学分子瘤学
背景情况:
- 恶性瘤需要代谢重编程,以使癌细胞在恶劣的瘤微环境中生存.
- 自,一种代谢过程,降解细胞内成分,以帮助处于压力下的细胞.
- 虽然在早期的癌症中具有保护作用,但在晚期的癌症阶段,自会被上调,从而支持瘤的生长.
研究的目的:
- 审查自在癌症中的双重作用,从限制致癌症到促进瘤进展.
- 探索癌细胞和瘤微环境中自的机制.
- 讨论在癌症治疗中准自的治疗潜力.
主要方法:
- 关于自在癌症中的作用的文献综述.
- 在致癌和瘤支持过程中,自的基础是分子机制的分析.
- 检查针对自的治疗策略.
主要成果:
- 自作为早期致癌的瘤抑制剂.
- 瘤细胞和瘤微环境利用自来增强生存和进展.
- 与自相关的蛋白质在癌症发展中发挥着多方面的作用.
结论:
- 自是癌症中关键的代谢调节剂,通常用于瘤进展.
- 准自为各种癌症类型提供了可行的治疗途径.
- 了解自的复杂作用是开发有效的癌症治疗的关键.
相关概念视频
Delivery Pathways to the Lysosome
8.7K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.7K
Autophagy
5.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.6K
Autophagic Cell Death
4.3K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
The Intrinsic Apoptotic Pathway
8.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K


